GLAND.NS Profit & Loss

Gland Pharma Ltd.

Profit & Loss · 4 years on file (FY2022-23 to FY2025-26) · fetched 2026-08-24 01:36

Line item	FY2022-23	FY2023-24	FY2024-25	FY2025-26	Source (XBRL element)
Revenue from Operations	₹36.25 Bn	₹56.65 Bn	₹56.17 Bn	₹64.31 Bn	RevenueFromOperations
Gross Revenue (incl. inter-segment)	N/A	N/A	N/A	N/A	SegmentRevenueFromOperations
Other Income	₹2.40 Bn	₹1.70 Bn	₹2.14 Bn	₹3.16 Bn	OtherIncome
Total Income	₹38.65 Bn	₹58.35 Bn	₹58.30 Bn	₹67.47 Bn	Income
Cost of Materials Consumed	₹17.17 Bn	₹20.22 Bn	₹19.72 Bn	₹22.40 Bn	CostOfMaterialsConsumed
Purchases of Stock-in-Trade	₹0.16 Bn	₹0.23 Bn	₹0.14 Bn	₹0.07 Bn	PurchasesOfStockInTrade
Changes in Inventories	₹-0.47 Bn	₹1.28 Bn	₹1.03 Bn	₹-0.03 Bn	ChangesInInventoriesOfFinishedGoodsWorkInProgressAndStockInTrade
Employee Benefit Expense	₹4.03 Bn	₹12.57 Bn	₹14.02 Bn	₹16.29 Bn	EmployeeBenefitExpense
Finance Costs	₹0.07 Bn	₹0.26 Bn	₹0.42 Bn	₹0.33 Bn	FinanceCosts
Depreciation and Amortisation	₹1.47 Bn	₹3.45 Bn	₹3.78 Bn	₹4.24 Bn	DepreciationDepletionAndAmortisationExpense
Other Expenses	₹5.11 Bn	₹9.02 Bn	₹8.56 Bn	₹9.29 Bn	OtherExpenses
Total Expenses	₹27.54 Bn	₹47.02 Bn	₹47.67 Bn	₹52.58 Bn	Expenses
Profit Before Exceptional Items and Tax	₹11.11 Bn	₹11.33 Bn	₹10.63 Bn	₹14.89 Bn	ProfitBeforeExceptionalItemsAndTax
Exceptional Items	₹-0.56 Bn	₹0.00 Bn	₹0.00 Bn	₹-0.24 Bn	ExceptionalItemsBeforeTax
Profit Before Tax	₹10.55 Bn	₹11.33 Bn	₹10.63 Bn	₹14.65 Bn	ProfitBeforeTax
Tax Expense	₹2.74 Bn	₹3.60 Bn	₹3.64 Bn	₹4.37 Bn	TaxExpense
Net Profit (incl. minority interest)	₹7.81 Bn	₹7.72 Bn	₹6.99 Bn	₹10.27 Bn	ProfitLossForPeriod
Net Profit (to shareholders)	₹7.81 Bn	₹7.72 Bn	₹6.99 Bn	₹10.27 Bn	ProfitOrLossAttributableToOwnersOfParent
Basic EPS	₹47.44	₹46.90	₹42.40	₹62.35	BasicEarningsLossPerShareFromContinuingAndDiscontinuedOperations
Diluted EPS	₹47.43	₹46.89	₹42.40	₹62.28	DilutedEarningsLossPerShareFromContinuingAndDiscontinuedOperations

Every figure above is the exact value of the named XBRL element from GLAND.NS's cached filing for that year — nothing here is estimated or backfilled. A company shows one column per year StockProof actually has data for — never padded with blank years. Rows shown as N/A are genuinely not disclosed under that year's filing format (see peer comparison for how other Healthcare companies compare).